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Ubiquitin (Ub)-conjugating enzymes (E2s) and ubiquitin ligases (E3s) catalyze the attachment of Ub to
lysine residues in substrates and Ub during monoubiquitination and polyubiquitination. Lysine selection is
important for the generation of diverse substrate-Ub structures, which provides versatility to this pathway in
the targeting of proteins to different fates. The mechanisms of lysine selection remain poorly understood, with
previous studies suggesting that the ubiquitination site(s) is selected by the E2/E3-mediated positioning of a
lysine(s) toward the E2/E3 active site. By studying the polyubiquitination of Sic1 by the E2 protein Cdc34 and
the RING E3 Skp1/Cul1/F-box (SCF) protein, we now demonstrate that in addition to E2/E3-mediated
positioning, proximal amino acids surrounding the lysine residues in Sic1 and Ub are critical for ubiquitina-
tion. This mechanism is linked to key residues composing the catalytic core of Cdc34 and independent of SCF.
Changes to these core residues altered the lysine preference of Cdc34 and specified whether this enzyme
monoubiquitinated or polyubiquitinated Sic1. These new findings indicate that compatibility between amino
acids surrounding acceptor lysine residues and key amino acids in the catalytic core of ubiquitin-conjugating
enzymes is an important mechanism for lysine selection during ubiquitination.
Protein ubiquitination plays a fundamental role in most cel-
lular processes and involves three classes of enzymes (22).
First, the 8-kDa protein ubiquitin (Ub) forms a thioester bond
with the E1 Ub-activating enzyme. Ub is then transferred from
E1 to the active-site cysteine of E2. Finally, E2s in conjunction
with an E3 transfer Ub to a substrate lysine to form an isopep-
tide bond. E3 ligases are important for substrate recognition,
and two major families exist. The RING (really interesting new
gene) finger E3s, which lack catalytic activity, recruit the sub-
strate and E2 into one complex to facilitate ubiquitination (19).
Catalytic HECT (homologous to E6-AP carboxyl terminus)
E3s accept Ub from E2 via a catalytic cysteine and then trans-
fer Ub to a substrate lysine (22). The versatility of Ub in
regulating different processes derives from its ability to be
conjugated as a monomer (monoubiquitination) or polymer
(polyubiquitination) to substrate lysines. Since Ub contains
seven lysines, polyubiquitination can generate chains with dif-
ferent topologies (18). Monoubiquitination can regulate DNA
repair, viral budding, trafficking, and gene expression (17).
Polyubiquitination through Ub K11, K29, or K48 results in
proteasomal degradation, while K63-linked Ub chains function
in kinase activation, DNA damage tolerance, signal transduc-
tion, and endocytosis (17). In RING E3s the mode of ubiquiti-
nation (mono- or polymeric) and Ub linkage specificity are
determined by E2, while HECT E3s specify the mode of ubiq-
uitination with this family (11, 12).
The mechanisms that control mono- or polyubiquitination,
chain topology, and lysine selection are poorly understood.
Insights into this area have come from studies of the RING E3
ligase Skp1-Cdc53/cullin F-box (SCF) protein and its cognate
E2, Cdc34, (19). One critical substrate of the budding yeast
SCFCdc4/Cdc34 complex (superscript indicates the F-box pro-
tein) is Sic1. Sic1 is an inhibitor of the cyclin-dependent kinase
(CDK) Cdc28 (29), containing a CDK-inhibitory domain
within its C-terminal 70 amino acids (9). In Saccharomyces
cerevisiae, G1-S-phase cell cycle progression depends on the
SCFCdc4/Cdc34-mediated polyubiquitination of Sic1 on at least
one of the six N-terminal lysine residues (K32, K36, K50, K53,
K84, and K88) via K48-linked Ub chains, leading to its pro-
teasomal degradation (9, 20). A Sic1 mutant missing these six
lysines is still ubiquitinated on the remaining 14 lysines in vitro
but is not degraded and is stable in vivo, leading to cell cycle
arrest (20).
While a Ub chain on any one of six Sic1 N-terminal lysines
sustains proteolysis, the turnover rates vary by 5-fold between
the K36 and K84 sites, indicating that the context of the Ub
chain is important (20). How SCFCdc4/Cdc34 ubiquitinates dif-
ferent Sic1 lysines and whether a lysine preference exists are
poorly understood, but a “positioning model” has been pro-
posed, where E3 positions substrate lysines favorably for the
attack of the E2Ub thioester bond (19, 37). Previous studies
suggested that the number of substrate ubiquitination sites
correlates with the number of its F-box protein binding sites (8,
33, 37). For example, the ubiquitination of -catenin and IB
is directed by a single high-affinity F-box protein binding site,
and changes to the distance between the binding site and the
lysine affect catalysis by 2-fold (37). The phosphorylation of
Sic1 on multiple CDK sites at the N terminus generates several
low-affinity Cdc4 binding sites that dynamically bind Sic1 to the
single site of Cdc4 in various geometries, leading to ubiquiti-
nation on numerous lysines. The directed binding of Sic1 to
Cdc4 through a single artificial high-affinity binding site at the
extreme N terminus confines efficient ubiquitination to lysines
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K84 and K88 (33). Sic1 lysine selection flexibility may also be
achieved by the dimerization of the RING E3/E2 complex (8,
33). In addition, the neddylation of the cullin subunit induces
conformational variation to the E2, enhances the recruitment
of E2 to SCF, and brings substrate lysines toward the
Cdc34Ub thioester to accommodate the ubiquitination of
different lysines (6, 25). Lysine selection flexibility may also be
achieved by the release of the ubiquitin-charged Cdc34Ub
from SCF to transfer Ub to different substrate lysines, as pro-
posed by the “hit-and-run” hypothesis (5). Apart from higher-
order structures contributing to lysine selection flexibility,
studies with the human anaphase-promoting complex (APC/C)
RING E3 and its E2, UbcH10, have identified a sequence
motif adjacent to acceptor lysines, termed the TEK box, which
is important for lysine selection (11).
Similar to the E3-mediated positioning of substrate lysines,
structural aspects of E2s position Ub lysines to generate Ub
chains of different topologies by RING E3/E2 complexes (11,
12). Structural studies of Mms2/Ubc13-Ub demonstrate that
this complex assembles so that K63 of Ub is positioned prox-
imal to the Ubc13-Ub thioester bond during Ub chain forma-
tion (35). Similarly, Cdc34 dimerization, a noncovalent Ub
binding domain (UBD), and structural constraints such as an
acidic loop region were suggested previously to position K48 of
Ub for the attack of the Cdc34Ub thioester bond (21, 36).
However, E2s such as human UbcH5 utilize all Ub lysines but
display a preference for K11, K48, and K63, indicating less
structural constraint and that other mechanisms contribute to
Ub lysine preference (12).
To further elucidate the mechanisms of lysine specificity, we
assessed the SCFCdc4/Cdc34-mediated ubiquitination of Sic1’s
N-terminal lysines and K48 in Ub. SCFCdc4/Cdc34 displayed a
strong preference for Sic1 K53. Changes to proximal amino
acids regulated the rate of ubiquitination in Sic1 and K48 of
Ub. This was linked to key residues composing the catalytic
core of Cdc34. The mutation of these core sites differentially
affected Cdc34 preference toward lysines on Sic1 or Ub K48.
Our studies demonstrate that in addition to the importance of
the SCF/Cdc34-mediated positioning of lysines, efficient catal-
ysis is dependent on residues surrounding ubiquitinated lysines
and their compatibility with the Cdc34 catalytic core residues.
We propose that this compatibility is an important mechanism
for lysine selectivity during ubiquitination.
MATERIALS AND METHODS
Plasmids, yeast strains, and cultures. The plasmids and yeast strains used in
this study are described in Tables 1 and 2. Mutations were introduced by site-
directed mutagenesis according to the manufacturer’s instructions (QuikChange;
Stratagene) and confirmed by DNA sequencing. To assess the ability of the
Cdc34 mutants to support growth, cdc34 deletion strain YMS034 containing
maintenance plasmid pURA3-CDC34 was transformed with tester plasmids
(pLEU2) expressing wild-type Cdc34(YSA) or the mutant alleles under the
control of the CDC34 promoter. Cells were grown on medium selective for both
plasmids or on medium selective for the tester plasmid and the loss of the
maintenance plasmid (5-fluoroorotic acid [5-FOA]) (4) for 3 days at 30°C. For
drop test analysis, yeast cells were grown to an optical density at 600 nm (OD600)
of 0.8 at 30°C. Serial 10-fold dilutions were spotted onto plates and incubated at
the indicated temperatures for 2 to 5 days.
Analysis of Sic1 in vivo. Strain YMS035 was transformed with the indicated
single-lysine Sic1 derivatives in plasmid p416Gal1 under the control of the strong
GAL1 promoter. A drop test analysis was performed with plates supplemented
with either glucose (2%, wt/vol) or galactose (2%, wt/vol) for 2 to 5 days at 30°C.
For analysis of Sic1 stability, the expression of Sic1 was induced in exponentially
growing cells with galactose (2%, wt/vol) for 4 h at 30°C. Concurrently, the cells
were arrested in G1 phase by adding 15 g/ml -factor for 2 h and then adding
a further 15 g/ml -factor for the remaining 2 h. Sic1 expression was stopped,
and cells were released into the cell cycle by centrifugation to collect the cells and
then resuspending them in yeast extract-peptone-dextrose (YPD) medium. Sam-
ples were taken at the indicated times, and cell extracts were prepared and
analyzed by immunoblotting with His5 antibody to detect His6-tagged Sic1, Clb5
(sc-6704; Santa Cruz), and actin antibody as a loading control. For quantitation,
Sic1 levels were normalized according to actin levels and are expressed as the
remaining Sic1 relative to the time point of 0 min (100%).
Expression and purification of recombinant proteins. Recombinant Cdc34,
Sic1, and Ub were expressed in Escherichia coli strain Rosetta BL21(DE3)pLysS
(Novagen). Cultures were grown in LB with 100 g/ml ampicillin and 50 g/ml
chloramphenicol at 37°C to an OD600 of 0.8, and expression was induced by the
addition of 0.75 mM isopropyl--D-thiogalactoside (IPTG) for 3 h at 37°C. Cells
were harvested and lysed, and proteins were purified by affinity chromatography
on Ni-nitrilotriacetic acid (NTA) agarose (Qiagen) as described previously (24).
Recombinant SCFCdc4 was prepared as described previously (24).
32P labeling of Sic1, Cdc34, and Ub. CDK-mediated phosphorylation to gen-
erate 32P-labeled Sic1 was performed as described previously (24, 26). Ub was
phosphorylated and 32P labeled by cyclic AMP (cAMP)-dependent protein ki-
nase (PKA; NEB) on the PKA motif in the presence of [-32P]ATP. Cdc34 was
phosphorylated by protein kinase CK2 (NEB) in the presence of [-32P]ATP
(24).
SCFCdc4/Cdc34-dependent ubiquitination of Sic1. Ubiquitination reaction
mixtures contained 100 nM yeast E1 (AG Scientific), 1 M Cdc34, 25 nM
SCFCdc4, 40 M Ub or Ub(K0) (Boston Biochem), and 0.15 M 32P-labeled Sic1
in UB buffer (50 mM Tris-HCl [pH 7.5], 50 mM potassium acetate, 2.5 mM
magnesium acetate, 1 mM dithiothreitol [DTT], 2 mM ATP). After incubation
for 60 min at 26°C, reactions were stopped by the addition of SDS-Laemmli
buffer to the mixtures and boiling, and proteins were separated by SDS-PAGE.
Sic1 was visualized by autoradiography and quantified by PhosphorImager anal-
ysis. To prepare monoubiquitinated 32P-labeled Sic1 K32 and 32P-labeled Sic1
K53, reactions were carried out as described above, with 1.5 M Cdc34(YDA)
and Ub or Ub(K48o). After SDS-PAGE, monoubiquitinated 32P-labeled Sic1
K32 and 32P-labeled Sic1 K53 were eluted from gel slices in 0.1 M Tris-HCl (pH
6.8) at 23°C overnight, concentrated by acetone precipitation in the presence of
5% (wt/vol) sucrose, and resuspended in UB buffer. As a control, 32P-labeled
Sic1 K53 was prepared in the same way except that Ub(K48o) was omitted from
the preubiquitination reaction.
Autoubiquitination of Cdc34 and formation of Ub2. Reaction mixtures con-
tained 150 nM yeast E1 (AG Scientific), 1 M Cdc34, and 15 M 32P-labeled Ub
in UB buffer. For the autoubiquitination of 32P-labeled Cdc34, 0.5 M Cdc34
and 40 M Ub were employed. After incubation for 60 min at 26°C, reactions
were stopped by the addition of SDS-Laemmli buffer to the mixtures and boiling.
Proteins were separated by SDS-PAGE and visualized by autoradiography.
RESULTS
Sequence-dependent ubiquitination of Sic1 by SCFCdc4/
Cdc34 is linked to residues proximal to the target lysine, which
controls proliferation in S. cerevisiae. It is not clear if Sic1’s
physiologically relevant N-terminal lysines (K32, K36, K50,
K53, K84, and K88) are differentially ubiquitinated by SCFCdc4/
Cdc34. Hence, we compared the monoubiquitinations of phos-
phorylated Sic1 derivatives that contained only a single lysine
at these positions with SCFCdc4/Cdc34 and lysine-less Ub,
Ub(K0), to prevent Ub chain elongation. Monoubiquitinations
of the Sic1 mutants varied substantially. While the K53 variant
displayed the highest level of ubiquitination, K32, K36, K50,
K84, and K88 were substantially less ubiquitinated (normalized
activities relative to those of K53 standard deviations [SD] of
17.0%  4.0% for K32, 15.3%  5.9% for K36, 56.2%  3.6%
for K50, 100% for K53, 24.8%  11.8% for K84, and 23.0% 
3.1% for K88) (Fig. 1A).
Previous work has shown that altering the spacing between
the ubiquitinated lysine and an F-box binding site in the sub-
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strate by 4 to 8 residues affected the rate of ubiquitination by
2-fold, with a lysine positioned 9 or 10 residues away being
optimal (37). We examined whether the spacing between the
five N-terminal CDK phosphorylation sites that are important
for Cdc4 binding (T5, T45, S69, S76, and S80) of Sic1 (14) and
the six lysines may explain the differences in their levels of
ubiquitination (Fig. 1B). The binding of Sic1 to Cdc4 requires
the phosphorylation of at least five of its seven N-terminal
CDK sites, trapping Sic1 on the single receptor site of Cdc4
(14–16). All the single-lysine Sic1 derivatives in this study dis-
played the characteristic slower-migrating electrophoretic mo-
bility similar to that of fully phosphorylated wild-type Sic1
(Sic1 Wt) or mutant lysine-less Sic1 (20, 21), indicating similar
phosphorylation levels. In addition, the lysine-less Sic1 mutant
TABLE 1. Plasmids used in this study
Plasmid Description Reference or source
pET15b-Cdc34 Wild-type Cdc34(YSA) with N-terminal His6 tag in pET15b (Stratagene) 24
pET15b-Cdc34(Y89N) Cdc34(NSA) This study
pET15b-Cdc34(S139D) Cdc34(YDA) This study
pET15b-Cdc34(S139E) Cdc34(YEA) This study
pET15b-Cdc34(S139A) Cdc34(YAA) This study
pET15b-Cdc34(S139T) Cdc34(YTA) This study
pET15b-Cdc34(A141L) Cdc34(YSL) This study
pET15b-Cdc34(Y89N,S139D) Cdc34(NDA) This study
pET15b-Cdc34(S138D,A141L) Cdc34(YDL) This study
pET15b-Cdc34(Y89,A141L) Cdc34(NSL) This study
pET15b-Cdc34(Y89N,S138D,A141L) Cdc34 (NDL) This study
pRS415-Cdc34(Wt) Wild-type Cdc34(YSA) under the control of the CDC34 promoter in
pRS415-LEU2 (Stratagene)
24
pRS415-Cdc34(Y89N) Cdc34(NSA) This study
pRS415-Cdc34(S139D) Cdc34(YDA) This study
pRS415-Cdc34(S139E) Cdc34(YEA) This study
pRS415-Cdc34(S139A) Cdc34(YAA) This study
pRS415-Cdc34(S139T) Cdc34(YTA) This study
pRS415-Cdc34(A141L) Cdc34(YSL) This study
pRS415-Cdc34(Y89N,S139D) Cdc34(NDA) This study
pRS415-Cdc34(S138D,A141L) Cdc34(YDL) This study
pRS415-Cdc34(Y89,A141L) Cdc34(NSL) This study
pRS415-Cdc34(Y89N,S138D,A141L) Cdc34(NDL) This study
pYX212-Cdc34 2m; TPI promoter 28
pES12-Cdc34(1-244) YEp96 derivative; CUP1 promoter; TRP1 Cdc34(1-244) 30
pRSETb-Sic1(Wt) Sic1 with N-terminal His6 tag in pRSETb (Invitrogen) 24
pET11b-Sic1(K32) K32-only Sic1 20
pET11b-Sic1(K36) K36-only Sic1 20
pET11b-Sic1(K50) K50-only Sic1 20
pET11b-Sic1(K53) K53-only Sic1 This study
pET11b-Sic1(K84) K84-only Sic1 20
pET11b-Sic1(K88) K88-only Sic1 This study
pET11b-Sic1 (Q31F T33N) K32-only Sic1(Q31F/T33N) This study
pET11b-Sic1(Q31D T33D) K32-only Sic1(Q31D/T33D) This study
pET11b-Sic1(T33D) K32-only Sic1(T33D) This study
pET11b-Sic1(G30D) K32-only Sic1(G30D) This study
pET11b-Sic1(T49P) K50-only Sic1(T49P) This study
pET11b-Sic1(T49V S51R) K50-only Sic1(T49V/S51R) This study
pET11b-Sic1(F52P N54S) K53-only Sic1(F52P/N54S) This study
pET11b-Sic1(F52V N54R) K53-only Sic1(F52V/N54R) This study
pET11b-Sic1(V87T R89S) K88-only Sic1(V87T/R89S) This study
pET11b-Sic1(V87F R89N) K88-only Sic1(V87F/R89N) This study
pET15b-hUb Human ubiquitin; N-terminal His6 tag; PKA site; hemagglutinin tag in
pET15b (Stratagene)
32
pET15b-hUb(G47Q) Ub(G47Q) This study
pET15b-hUb(Q49P) Ub(Q49P) This study
pET15b-hUb(L50S) Ub(L50S) This study
p416Gal1-Sic1(Wt) Sic1-His6 in p416Gal1 (URA3 CEN6/ARSH4) (from J. Heierhorst) This study
p416Gal1-Sic1(K0) Lysine-less Sic1 This study
p416Gal1-Sic1(K32) K32-only Sic1 This study
p416Gal1-Sic1(K36) K36-only Sic1 This study
p416Gal1-Sic1(K50) K50-only Sic1 This study
p416Gal1-Sic1(K53) K53-only Sic1 This study
p416Gal1-Sic1(K84) K84-only Sic1 This study
p416Gal1-Sic1(K88) K88-only Sic1 This study
p416Gal1-Sic1(Q31F T33N) K32-only Sic1(Q31F/T33N) This study
p416Gal1-Sic1(F52P N54S) K53-only Sic1(F52P/N54S) This study
p416Gal1-Sic1(F52V N54R) K53-only Sic1(F52V/N54R) This study
2318 SADOWSKI ET AL. MOL. CELL. BIOL.
binds SCFCdc4 with the same affinity as that of Sic1 Wt (21).
Examination of the spacing between the ubiquitinated lysines
and the different CDK phosphorylation sites (Fig. 1B) revealed
no obvious relationship to their degree of ubiquitination. For
example, while K36 and K53 are positioned at a similar dis-
tance relative to T45 (9 and 8 residues), K53 is ubiquitinated
6.5-fold-more efficiently than K36. In addition, K84 and K88
are 8 residues upstream of S76 and S80, respectively, which is
identical to the spacing between T45 and K53, yet the ubiq-
uitination of K84 and K88 is 4-fold lower than that of K53 (Fig.
1A). Given the highly dynamic equilibrium binding of the
phospho-Sic1/Cdc4 interaction (14–16), it is plausible that the
ubiquitination level of a particular lysine is not determined by
its spacing to a single low-affinity Cdc4 binding site. However,
it is also possible that ubiquitinated residues located further
from the phosphorylation sites in the primary sequences may
actually be located closer in the tertiary structure. These ob-
servations prompted us to investigate if other determinants
may be important; e.g., whether the local amino acid sequence
environment of the lysine contributes to the catalysis efficiency
remains uncharacterized. Therefore, we changed the flanking
residues of poorly ubiquitinated Sic1 lysines (K32, K84, and
K88) to those of efficiently ubiquitinated sites (K50 and K53)
and vice versa. The rationale was to determine if keeping the
lysine position unchanged but altering its proximal amino acids
can alter the level of ubiquitination. We generated a set of
single-lysine Sic1 derivatives, including K53-like K32(Q31F/
T33N) and K88(V87F/R89N), K50-like K88(V87T/R89S), K84-
like K53(F52P/N54S) and K50(T49P), and K88-like K53
(F52V/N54R) and K50(T49V/S51R). We also generated the
K32 derivatives K32(Q31D/T33D), K32(T33D), and K32
(G30D) based on our observation that a lysine embedded in an
aspartate-rich sequence motif (DDKDP) was efficiently ubiq-
uitinated by Cdc34 (data not shown). While the K53-like
K32(Q31F/T33N) derivative and the T33D and Q31D/T33D
mutants displayed between 2- and 3-fold-higher K32 ubiquiti-
nation levels, the G30D mutation reduced activity by 2-fold
relative to that of K32 within the wild-type sequence [normal-
ized activities relative to wild-type K32  SD of 100% for K32,
294.9%  66.3% for K32(Q31F/T33N), 200.2%  11.1% for
K32(Q31D/T33D), 241.5%  24.3% for K32(T33D), and
51.1%  1.3% for K32(G30D)] (Fig. 1C, lanes 1 to 5). Simi-
larly, the level of K88 ubiquitination with the K50-like
K88(V87T/R89S) and the K53-like K88(V87F/R89N) was in-
creased 50% relative to that of K88 within its wild-type
sequence context [100% for K88, 148.8%  18.4% for
K88(V87T/R89S), and 156.4%  41.7% for K88(V87F/
R89N)] (Fig. 1C, lanes 12 to 14). Conversely, the levels of
ubiquitination of K50 were decreased by 5- and 2-fold with the
K84-like K50(T49P) and the K88-like K50(T49V/S51R) mu-
tants, respectively, compared to wild-type K50 [100% for K50,
19.3%  5.4% for K50(T49P), and 51.8%  19.5% for
K50(T49V/S51R)] (Fig. 1C, lanes 6 to 8). The level of ubiq-
uitination of the K84- and K88-like K53 derivatives also de-
creased by 5- and 2-fold, respectively, compared to wild-type
K53 [100% for K53, 17.4%  6.1% for K53(F52P/N54S), and
43.9%  18.4% for K53(F52V/N54R)] (Fig. 1C, lanes 9 to 11).
Hence, amino acids proximal to the lysine regulated the effi-
ciency of ubiquitination in a predictable manner. To clarify this
issue further, we performed kinetic studies. Assessment of the
initial reaction rates against the concentration of single-lysine
Sic1 K32 and its K53-like and T33D mutants revealed reaction
rates, Vmax values, of 7.0, 18.1, and 15.1 fmol/min, respectively,
while the estimated Km values were 0.31, 0.30, and 0.32 M,
respectively (Fig. 1D), consistent with the previously estimated
Km of 0.25 M for Sic1 binding to Cdc4 (33). Although T33 is
one of the seven CDK consensus phosphorylation sites at the
N terminus (T2, T5, T33, T45, S69, S76, and S80) (15), T33
phosphorylation does not contribute to Cdc4 binding (14),
consistent with our results that mutations of this site did not
alter the apparent Km. With Sic1 K53 and its K84- and K88-like
mutants, the estimated Vmax values were 49.4, 21.3, and 28.8
fmol/min, while the estimated Km values were 0.19, 0.32, and
0.28 M, respectively (Fig. 1D). Since the major effect was on
the Vmax rather than the Km, this suggests that mutations of
residues around Sic1 lysines affected the rate at which the
lysine acted as a nucleophile to attack the Cdc34Ub thioester
bond rather than the affinity of Sic1 toward the Cdc4 subunit
of SCF.
Next, we assessed whether the sequence-dependent ubiquiti-
nation of Sic1 lysines is physiologically relevant. Since the
proliferation of S. cerevisiae is dependent on the ubiquitination
and proteolysis of Sic1 (29), we compared the growth rates of
yeast strains overexpressing single-lysine Sic1 derivatives. As
controls, we analyzed the growth of cells containing either
empty plasmid, wild-type Sic1 (Sic1 Wt), or lysine-less Sic1
(Sic1 K0). Immunoblotting confirmed that all Sic1 constructs
were expressed to similar levels (results not shown). The in-
duced expression of ectopic Sic1 Wt slightly reduced cell
growth compared to the empty vector, while the expression of
Sic1 K0 led to growth arrest (Fig. 2A). Cells expressing the Sic1
single-lysine K32, K36, K50, K53, K84, and K88 mutants grew
at rates between these two extremes (Fig. 2A). Compared to
cells with the empty vector, all of the cells expressing the
different Sic1 mutants displayed reduced growth rates, indicat-
ing that they retain biological activity and that mutations do
not lead to major structural defects. This is consistent with
previous studies demonstrating that the N-terminal region
(amino acids 1 to 90) of Sic1 has no appreciable stable sec-
ondary structure (14, 15), that the CDK-inhibitory region of
Sic1 is localized within the C-terminal 70 amino acids (9), and
that a Sic1 mutant with all 20 lysine residues replaced with
arginines retains full CDK-inhibitory activity (20).
Cells expressing Sic1 K53 grew the fastest, followed by those
expressing Sic1 K50, while cells with the remaining Sic1 mu-
tants grew slower (Fig. 2A). While this growth correlated with
TABLE 2. Yeast strains used in this study
Strain Description Reference or source
YMS034 MATa ura3-1 trp1-1 ade2-1 leu2-3,112 his3-11,15 can1-100 cdc34::kanMX4 pYX212-Cdc34 24
YMS035 MATa ura3-1 trp1-1 ade2-1 leu2-3,112 his3-11,15 can1-100 cdc34::kanMX4 pRS415-Cdc34(Wt) This study
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the rates of ubiquitination of the different Sic1 single-lysine
derivatives by SCFCdc4/Cdc34 (Fig. 1A), it is possible that the
position of the Ub chain within Sic1 might affect their protea-
somal degradation and growth effects (20). To exclude this
possibility, we kept the lysine position the same and tested
whether changes to the proximal amino acids surrounding Sic1
K53 has an impact on the rate of proliferation in S. cerevisiae.
Cells expressing the K84- or K88-like K53 mutant grew slower
than cells expressing the K53 wild-type derivative (Fig. 2A).
Hence, the growth rate of cells expressing Sic1 K53 and their
respective proximal amino acid mutants correlated with their
relative ubiquitinations in vitro.
Finally, we tested whether the differences in the rates of
ubiquitination of different Sic1 variants affected their degrada-
tion rates in vivo. We tested wild-type Sic1 K53 and its poorly
ubiquitinated mutant counterpart, K84-like Sic1 K53. In addi-
tion, we tested wild-type Sic1 K32 and its improved ubiquiti-
nated mutant counterpart, K53-like Sic1 K32. Cells were first
arrested in the G1 phase by -factor arrest and by Sic1 expres-
sion, which was induced with galactose. Following the removal
of -factor and galactose to induce G1-S-phase cell cycle pro-
gression and stop ectopic Sic1 expression, pulse-chase time
course experiments revealed that the degradation of the K84-
like Sic1 K53 mutant was substantially slower than that of
wild-type Sic1 K53 (Fig. 2B). Conversely, the degradation of
K53-like Sic1 K32 was noticeably faster than that of wild-type
Sic1 K32 (Fig. 2B). Analysis of the kinetics of the appearance
of the S-phase cyclin Clb5 by Western blotting confirmed that
Sic1 was degraded when cells were progressing from G1 to S
phase. Therefore, the rate of degradation of these Sic1 variants
correlates with their rate of ubiquitination in vitro (Fig. 1C
and 2B).
Tyrosine 89, serine 139, and alanine 141 of Cdc34 are im-
portant for cell viability. The above-described findings sug-
gested that key residues in the catalytic region of Cdc34 were
involved. The catalytic domain among E2s is relatively con-
FIG. 1. Amino acids proximal to lysines regulate ubiquitination of Sic1 by SCFCdc4/Cdc34. (A) Monoubiquitination of single-lysine Sic1
derivatives by SCFCdc4/Cdc34 with lysine-less Ub [Ub(K0)]. As a control, Cdc34 was omitted from the reaction mixture (lane 1). Monoubiquiti-
nated Sic1 (Sic1-Ub1) levels were normalized relative to monoubiquitinated Sic1 (K53). Error bars represent the SD. Gaps indicate where
irrelevant lanes were removed from the same experiment. (B) Positions of CDK phosphorylation sites and the six physiologically relevant lysines
of Sic1 (top) and their local amino acid sequence environment (bottom). The gray box represents the CDK-inhibitory domain. (C) The indicated
single-lysine derivatives with changes to amino acids proximal to the lysine were subjected to the same analysis as that described above (A).
Monoubiquitinated Sic1 (Sic1-Ub1) was normalized relative to the levels of monoubiquitinated wild-type K32 (white bars), K50 (light gray bars),
K53 (gray bars), and K88 (black bars). Error bars represent the SD. (D) Effect of Sic1 concentration (15 to 800 nM) on the rate of monoubiq-
uitination. Monoubiquitinated Sic1 was quantified by PhosphorImager analysis to calculate the apparent Vmax and Km by nonlinear regression with
GraphPad Prism software. Data in parentheses indicate standard errors.
FIG. 2. Amino acids proximal to Sic1 lysines regulate proliferation of S. cerevisiae and degradation of Sic1. (A) Growth of yeast cells expressing
the indicated Sic1 derivatives. An empty plasmid (empty) and lysine-less Sic1 K0 were included as controls. Serial 10-fold dilutions of exponentially
growing cells were spotted onto plates with galactose to induce expression or without galactose as a control. (B) Cells were arrested in G1 phase
with -factor, and the expression of Sic1 K53 and Sic1 K53 K84-like (left), or Sic1 K32 and Sic1 K32 K53-like (right), was induced with galactose.
Cells were induced to enter the cell cycle, Sic1 expression was repressed by the addition of fresh medium, and samples were taken at the indicated
times. Cell extracts were prepared, and Sic1, actin, and Clb5 were detected by immunoblotting. Sic1 levels were quantified and normalized
according to the actin levels. The results are the means and ranges of data from two independent experiments.
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served, including those of Ub-like conjugating enzymes (22).
Studies of the SUMO E2-substrate complex of human Ubc9
and RanGAP1 revealed that Y87, D127, P128, and A129 of
Ubc9 around the active-site cysteine are in close proximity to
the RanGAP1 lysine and that the mutation of these sites im-
pairs sumoylation (2, 38). E2 sequence alignments revealed
that Y89, S139, P140, and A141 are the analogous sites in yeast
Cdc34 (Fig. 3A). In contrast to P140, which is almost entirely
conserved, divergence is found at the positions corresponding
to Y89, S139, and A141 of yeast Cdc34 (Fig. 3A). Site 89 has
the highest divergence, with tyrosine, asparagine, aspartate,
serine, threonine, glycine, or lysine at this position. Site 139
contains either serine or aspartate (and rarely glutamate), and
site 141 features alanine, leucine, or glutamine. E2s feature
only 11 different triplets from a possible 63 (Fig. 3A), suggest-
ing that only certain combinations are permissive for catalysis.
To define if yeast Cdc34 Y89, S139, and A141 (here referred to
as the core sites) are important for sequence-dependent ubiq-
uitination, we replaced these sites in Cdc34, individually or in
combination, with residues found at the corresponding posi-
tions in yeast Ubc4 (N80, D118, and L120), since these two E2s
diverge at all of these sites (Fig. 3A). We also replaced S139 of
Cdc34 with glutamate, alanine, and threonine, since our pre-
vious work showed that the corresponding site in hHR6A
(S120) regulated the activity of this E2 (27). For simplicity,
Y89, S139, and A141, are here indicated by a triplet single-
letter amino acid code, and a mutation is marked by the un-
derlined letter; e.g., YDA indicates the single-site mutation
S139D. Combinatorial mutagenesis generated a panel of single
(NSA, YDA, YAA, YEA, YTA, and YSL), double (NDA,
YDL, and NSL), and triple (NDL) mutants. Here, wild-type
Cdc34 is referred to as Cdc34.
We first assessed the importance of these sites for Cdc34
function in vivo. Since Cdc34 is essential for S. cerevisiae via-
bility, we monitored the mutants for their abilities to support
growth in the absence of endogenous Cdc34 by plasmid shuf-
fling in a cdc34 deletion strain (4). Immunoblotting con-
firmed the expression of the mutants at levels similar to that of
Cdc34 (Fig. 3D). Cells expressing either Cdc34 or the NSA,
YDA, NSL (Fig. 3B), YAA, YTA, and YEA mutants (results
FIG. 3. Y89, S139, and A141 of Cdc34 are important for viability of S. cerevisiae. (A) Sequence alignments of the core domains of E2s reveal
11 variations of the amino acid sequence analogous to Y89, S139, and A141 of yeast Cdc34. The three sites are highlighted by boxes and listed
in parentheses on the right. The active-site cysteine and the oxyanion-stabilizing asparagine are underlined. (B) The indicated Cdc34 mutants were
analyzed with the cdc34 deletion strain. An empty tester plasmid (empty) was included as a control. (C) Survivors of the experiment in panel B
were tested for growth by drop test analysis. (D) The ectopic expression of Cdc34 (lane 2) and the mutant alleles (lanes 3 to 12) from pRS415-LEU2
was analyzed by immunoblotting with polyclonal Cdc34 antibody in a derivative of cdc34 deletion strain YMS034 (MATa ura3-1 trp1-1 ade2-1
leu2-3,112 his3-11,15 can1-100 cdc34::kanMX4) (24), which was kept viable by the ectopic expression of truncated Cdc34 [pES12-Cdc34(1-244)]
(30). Full-length Cdc34 and the truncated derivative (residues 1 to 244) are indicated on the right. Empty plasmid (pRS415-LEU2) was employed
as a control (lane 1). Molecular masses (in kilodaltons) are indicated on the left.
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not shown) were viable, while cells expressing the YSL, NDA,
YDL, and NDL mutants did not grow (Fig. 3B). We analyzed
the survivors by drop test analysis. While the growth of cells
expressing Cdc34 was similar to that of cells expressing the
NSA or NSL mutant at 23°C, incubation at 37°C induced a
temperature-sensitive growth defect in the NSL mutant (Fig.
3C). Although cells with YSL were not viable (Fig. 3B), the
expression of the NSL double mutant rescued viability at 23°C
(Fig. 3B and C), indicating that the Y89N mutation compen-
sates conditionally for the lethal effect of the A141L mutation.
Cells expressing YAA, YTA, YDA, or YEA displayed a mod-
erate-to-severe slow-growth phenotype at 23°C compared to
Cdc34. Incubation at 37°C exacerbated the growth defect of
cells expressing the YDA, YEA, or YTA mutant (Fig. 3C).
Therefore, Y89, S139, and A141 play important roles, and only
certain combinations of amino acids support Cdc34 function in
vivo (Table 3).
Tyrosine 89, serine 139, and alanine 141 of Cdc34 are im-
portant for Sic1 ubiquitination. We next assessed whether
these core sites are important for the ubiquitination of Sic1.
Sic1 Wt has 20 lysines, and almost all of them are ubiquitinated
by SCFCdc4/Cdc34 in vitro (20). To evaluate only the ubiquiti-
nation of Sic1, we employed the chain-terminating Ub deriva-
tive Ub(K0). Cdc34 and YDA efficiently ubiquitinated Sic1 on
multiple sites, generating conjugates of 100 to 250 kDa (Fig.
4A, lanes 2 and 4, and B). YAA and YTA ubiquitinated fewer
Sic1 sites, as evidenced by conjugates of 100 kDa, and the
remaining mutants failed to generate conjugates of 	75 kDa
(Fig. 4A and B). Interestingly, the efficiency of the Cdc34
mutants in ubiquitinating Sic1 did not correlate with their
efficiency in supporting growth in S. cerevisiae. For example,
YDA was severely impaired in supporting growth of the
cdc34 strain but was as active as Cdc34 in ubiquitinating Sic1
(Fig. 3B and C and 4A and B). Conversely, NSA supported
growth to the same extent as Cdc34 but was substantially less
efficient in ubiquitinating Sic1 (Fig. 3B and C and 4A). To
determine if this was due to a change in the Sic1 lysine pref-
erence, we assayed the Cdc34 mutants for their abilities to
monoubiquitinate the N-terminal single-lysine Sic1 derivatives.
While YDA was as active as Cdc34 toward the single-lysine
Sic1 substrates, the other mutants showed reduced activity
(Fig. 4C). The overall activity profiles of the different mutants
toward Sic1 Wt and the single-lysine Sic1 mutants were similar
(Fig. 4A and C; summarized in Table 3), indicating that these
TABLE 3. Cdc34 mutants, their growth phenotypes, and their
ubiquitination activities toward Sic1 and K48 of ubiquitina
Cdc34
variant Mutation(s) Growth
Ubiquitination
Sic1 Ub K48
YSA Wild type 


 


 



NSA Y89A 


  


YDA S139D 
 (TS) 


 
YEA S139E 
 (TS) 

 
YAA S139A 


 
 


YTA S139T 
 (TS) 
 

YSL A141L   
NSL Y89N, A141L 
 (TS)  

NDA Y89N, S139D  
 
YDL S139D, A141L   
NDL Y89N, S139D, A141L   
a The Cdc34 variants and their mutations are shown. Their growth and
ubiquitination activities toward Sic1 lysines (Fig. 3 and 4) or K48 of ubiquitin
(Fig. 5 and 7A) are represented relative to those of wild-type Cdc34, where



, 

, and 
 represent wild-type, reduced, and poor growth/activity,
respectively, and  represents no growth/activity. TS indicates Cdc34 variants
that displayed temperature-sensitive growth at 37°C.
FIG. 4. Y89, S139, and A141 of Cdc34 are important for ubiquitination of Sic1. (A and B) Monoubiquitination of Sic1 Wt for 60 min (A) or
for the indicated times (B). (C) The indicated single-lysine Sic1 mutants were assessed with the indicated Cdc34 derivatives. No E2 represents
control with no Cdc34 added, or reactions were stopped at the indicated times (lanes 2 to 4, with Cdc34) or at 60 min. Gaps indicate where lanes
of the same experiment were rearranged for consistency.
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mutants did not noticeably alter their preference for particular
Sic1 lysine residues.
Cdc34 tyrosine 89 and serine 139 are critical determinants
in specifying Sic1 monoubiquitination or polyubiquitination
via K48 of Ub. The recognition and proteasomal degradation
of proteins requires a Ub chain of at least four Ubs (34).
Hence, the efficiency of the different Cdc34 mutants in sup-
porting the growth of the cdc34 yeast strain might be corre-
lated with their ability to polyubiquitinate via K48 of Ub. To
address this, we first monitored the polyubiquitination of Sic1
Wt with Ub(Wt). Sic1 Wt was efficiently polyubiquitinated by
Cdc34 and the YAA and YTA mutants, generating conjugates
of 	250 kDa (Fig. 5A, lanes 2, 10, and 12). The other mutants
generated lower-molecular-weight (MW) intermediates. Inter-
estingly, while the YDA mutant ubiquitinated all of the Sic1
Wt substrate, the majority of these conjugates were 150 kDa,
and time course experiments revealed that the YDA mutant
was impaired in chain elongation (Fig. 5B). To distinguish
between the ubiquitination of Sic1 lysines and K48 of Ub
during polyubiquitination, we assayed polyubiquitination with
the single-lysine derivative Sic1 K53. We specifically tested the
ability of the Cdc34 mutants to utilize K48 of Ub for chain
synthesis by employing Ub(K48o), which contained only a sin-
gle lysine at position 48. Cdc34 generated chains with up to
seven Ub molecules on Sic1 K53 (Fig. 5C, lane 2). While the
YAA and YTA mutants conjugated chains of similar lengths,
the YDA and YEA mutants were impaired in Ub chain exten-
sion, accumulating predominantly mono- and diubiquitinated
Sic1 K53 (Fig. 5C, lanes 4 and 10 to 12). Interestingly, the NSA
mutant generated chains of approximately four Ub molecules
FIG. 5. Y89 and S139 of Cdc34 affect different steps in Sic1 polyubiquitination. (A and B) Polyubiquitination of Sic1 Wt with Ub(Wt) for 60
min (A) or at the indicated times (B). (C) Sic1 K53 ubiquitination with Ub(K48o) was assessed with the indicated Cdc34 derivatives. Lane 1, no
Cdc34 added as a control. (D) To analyze Ub K48 chain elongation without preceding Sic1 ubiquitination, Sic1 K53-Ub(K48o)1 was used as a
substrate with Ub(K0) (lanes 1 to 7). As a control, Sic1 K53 was assayed under the same conditions (lanes 8 to 14). (E) The S139 mutants of Cdc34
do not change linkage specificity for other Ub lysines. Ub chain formation was monitored with Sic1 K32-Ub(Wt) as a substrate in the presence
of Ub(K48R). Gaps indicate where irrelevant lanes were removed from the images.
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but did not accumulate monoubiquitinated Sic1 K53, suggest-
ing that this mutant was efficient in Ub chain extension. All of
the other mutants were severely impaired in Sic1 K53 polyu-
biquitination (Fig. 5C, lanes 5 to 9).
To directly assess the ability of the Cdc34 Y89 and S139
mutants to utilize K48 of Ub for chain elongation independent
of the initial attachment on Sic1, we prepared a preubiquiti-
nated substrate with a single molecule of Ub with lysine only at
position 48, Ub(K48o), attached to Sic1 K53 [Sic1 K53-
Ub(K48o)1]. We assayed Ub chain elongation with lysine-less
Ub(K0) to terminate conjugation after the attachment of the
first Ub(K0) onto the Sic1 K53-Ub(K48o)1 substrate to gener-
ate only diubiquitinated Sic1 (Sic1-Ub2). Cdc34 readily conju-
gated Ub(K0) onto Sic1 K53-Ub(K48o)1, generating Sic1-Ub2
(Fig. 5D, lane 2). While the NSA, YAA, and YTA mutants
showed reduced activities, the YDA and YEA mutants were
almost entirely inactive (Fig. 5D, lanes 2 to 7). As a control, we
assayed the Cdc34 derivatives toward Sic1 K53 as a substrate.
Consistent with the results shown in Fig. 4C, Cdc34 and the
YDA mutant were equally active; the YEA, YAA, and YTA
mutants were less active; and the NSA mutant was substan-
tially impaired in Sic1 K53 monoubiquitination (Sic1-Ub1)
(Fig. 5D, lanes 9 to 14). Strikingly, the YDA and NSA mutants
displayed polar-opposite activities toward K53 of Sic1 and K48
of Ub. While the YDA mutant was efficient in Sic1 K53 ubiq-
uitination but impaired in polyubiquitin chain extension via Ub
K48 (Fig. 5D, lanes 4 and 11; summarized in Table 3), the NSA
mutant was impaired in Sic1 K53 ubiquitination but readily
ubiquitinated K48 of ubiquitin (Fig. 5D, lanes 3 and 10; sum-
marized in Table 3).
We next tested whether the mutation of S139 might change
linkage specificity by utilizing a non-K48 lysine(s) of Ub. We
preubiquitinated Sic1 K32 with Ub(Wt) to generate Sic1 K32-
Ub(Wt)1 as a substrate. To block the utilization of K48 in the
chain-extending Ub, we added Ub(K48R), which had six ly-
sines remaining. A change in linkage specificity would allow
the YDA mutant to conjugate Ub(K48R) to Sic1 K32-Ub
(Wt)1 or the YAA mutant to extend a Ub chain. Cdc34 con-
jugated predominantly a single molecule of Ub(K48R) onto
Sic1 K32-Ub(Wt)1, with minimal levels of triubiquitinated Sic1
K32 (Sic1-Ub3) (Fig. 5E, lane 2). YDA failed to efficiently
attach a single Ub(K48R) onto the preubiquitinated substrate,
while the YAA and YTA mutants terminated Ub chain elon-
gation after the attachment of the first molecule of Ub(K48R)
(Fig. 5E, lanes 3 to 5). Hence, the mutation of S139 in Cdc34
did not change the K48 linkage specificity.
Mutation of amino acids proximal to Ub K48 reactivates
polyubiquitination by the Cdc34 S139D mutant. Since amino
acids proximal to lysines in Sic1 determine the efficiency of
ubiquitination (Fig. 1C), amino acids proximal to K48 of Ub
may also be important during polyubiquitination. Since the
YDA mutant readily ubiquitinated Sic1 lysines but did not
utilize Ub K48, we investigated whether the mutation of resi-
dues around Ub K48 (GKQL) affected polyubiquitination.
Given the robust activity of the YDA mutant toward Sic1 K36
(Fig. 4C), we chose the sequence surrounding K36 as a tem-
plate (QKPS) and generated the single-site Ub derivatives
Ub(G47Q), Ub(Q49P), and Ub(L50S). We assessed these mu-
tants with Cdc34 and Sic1 K36 as substrates. Incubation with
Ub(Wt), Ub(Q49P), or Ub(L50S) generated high-molecular-
mass conjugates of 	250 kDa, while polyubiquitination was
severely impaired with Ub(G47Q) (Fig. 6A, lanes 1 to 4). With
Ub(Wt) and Ub(G47Q), the YDA mutant was impaired in
polyubiquitination, generating predominantly mono- and di-
ubiquitinated Sic1 K36 (Fig. 6A, lanes 6 and 7). Conversely,
Ub(Q49P) and Ub(L50S) supported polyubiquitination, gen-
erating high-molecular-mass conjugates of 	250 kDa, similar
to that observed with Cdc34 (Fig. 6A, lanes 8 and 9). Since
these mutations in Ub did not affect ubiquitination with Cdc34
and restored the activity of the YDA mutant, this strongly
suggested that these changes did not have major structural
effects on Ub. Time course experiments revealed that the YDA
mutant was almost as active as Cdc34 in the polyubiquitination
of Sic1 Wt with Ub(L50S) (Fig. 6B). Therefore, G47 of Ub is
critical during the catalysis of Ub K48. Studies with YDA
showed that, similar to Sic1 lysine ubiquitination, compatibility
between residues in the catalytic core of Cdc34 and residues
surrounding K48 of Ub is important for catalysis.
Sequence-dependent lysine specificity is an intrinsic and
E3-independent function of Cdc34. We next tested whether
FIG. 6. Mutation of residues proximal to Ub K48 reactivates YDA
in Ub chain synthesis. (A) Cdc34 and YDA were tested for their
abilities to generate Ub chains on Sic1 K36 with either Ub(Wt),
Ub(G47Q), Ub(Q49P), Ub(L50S), or Ub(K48R). Ub(K48R), which
was used as a control, has a lower MW than the other Ub derivatives,
as indicated by the lower mobility of monoubiquitinated Sic1 K36.
Gaps indicate where irrelevant lanes were removed. (B) The poly-
ubiquitination of Sic1 Wt (0.4 M) was assessed with either wild-type
Cdc34 (lanes 1 to 5) or the YDA mutant (lanes 6 to 10) with 20 M
Ub(L50S) at the indicated times.
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alterations in the activities of the Cdc34 mutants were inde-
pendent of SCFCdc4 by assessing them in autoubiquitination
reactions without SCFCdc4 and Sic1. Autoubiquitination and
the formation of unanchored Ub chains by E2s are frequently
used to measure their intrinsic activity in the absence of E3s
(13). Cdc34 autoubiquitinates four C-terminal lysine residues
(K273, K277, K293, and K294) (1) and can generate unan-
chored K48-linked Ub chains (21). Cdc34 efficiently generated
unanchored di-Ub (Ub2) with Ub(Wt) and autoubiquitinated
with high-molecular-mass Ub conjugates of 75 to 250 kDa
(Fig. 7A, lane 2). All the Cdc34 mutants showed reduced
activities in at least one of the two reactions. The YDA mutant
was active in autoubiquitination, with conjugates of70 to 250
kDa, but generated very low levels of di-Ub, indicating that it
was impaired in the catalysis of K48 Ub linkages (Fig. 7A, lane
4). Conversely, the YAA, YTA, and YEA mutants were less
active in autoubiquitination but generated di-Ub levels inter-
mediate to those of Cdc34 and the YDA mutant. The remain-
ing Cdc34 mutants were less active in both reactions. These
differential activities were similar to those observed in the
presence of SCFCdc4 (Fig. 4A and 5A). Therefore, sequence-
dependent lysine specificity is intrinsic to the Cdc34 mutants
and independent of SCF.
We also tested the activities of Cdc34 and the YDA mutant
with Ub(Wt), Ub(G47Q), Ub(Q49P), Ub(L50S), or Ub(K48R)
in autoubiquitination reactions. Cdc34 efficiently autoubiquiti-
nated K48-linked Ub chains with Ub(Wt), Ub(Q49P), or
Ub(P50S), generating high-MW conjugates, which were absent in
the reaction with Ub(K48R). Conversely, Ub(G47Q) severely
impaired autoubiquitination (Fig. 7B, lanes 1 to 5). While the
YDA mutant autoubiquitinated the same number of lysines as
Cdc34 with Ub(K48R), it failed to form Ub chains with Ub(Wt)
and Ub(G47Q) (Fig. 7B, lanes 5 to 7 and 10). In contrast, the
YDA mutant readily assembled high-MW Ub chains with
Ub(Q49P) and Ub(L50S) (Fig. 7, lanes 8 and 9). Time course
experiments revealed that the YDA mutant displayed a similar
activity in polyubiquitination with Ub(Q49P) and Ub(L50S) com-
pared to that of Cdc34 (Fig. 7C).
Assessment of the initial reaction rates against the concen-
tration of Ub(Wt), Ub(Q49P), and Ub(L50S) in autoubiquiti-
nation reactions with Cdc34 revealed similar apparent Vmax
values (339, 387, and 279 fmol/min, respectively) and Km values
(5.7, 8.3, and 5.7 M, respectively) (Fig. 7D). The YDA mu-
tant had a 3-fold-lower Vmax (107 fmol/min) and a lower Km
(3.4 M) with Ub(Wt) than did Cdc34, while the values with
Ub(Q49P) and Ub(L50S) were similar to those observed for
Cdc34 (Vmax values of 342 and 294 fmol/min, respectively, and
Km values of 5.8 and 5.2 M, respectively) (Fig. 7D). The
reduced activity of the YDA mutant with Ub(Wt) suggested
that the impaired utilization of K48 in Ub chain synthesis was
not due to the reduced binding and docking of Ub K48 to the
YDA catalytic region, since the Km was also slightly reduced,
but rather that K48 was a weaker nucleophile in attacking the
Cdc34Ub thioester bond. These studies show that compati-
bility between the catalytic core of Cdc34 and residues around
Ub K48 are important for polyubiquitination independent
of SCF.
DISCUSSION
Despite the importance of ubiquitination, the mechanisms
that control the selection of lysines on substrates and Ub are
poorly understood. Our studies demonstrate that compatibility
between amino acids proximal to acceptor lysines and residues
in the catalytic core of Cdc34 ultimately determines lysine
ubiquitination in substrates and Ub. This new concept expands
upon the current view that ubiquitination is dependent primar-
ily on the proximity of the lysine to the E2-thioester mediated
through positioning by E2/E3 (21, 37) and has important im-
plications for our understanding of the mechanisms of sub-
strate monoubiquitination and polyubiquitination.
Substrates such as Sic1, which are ubiquitinated on numer-
ous lysines, indicate that mechanisms for selecting spatially
separated lysines must exist. As described in the introduction,
several higher-order structural mechanisms contribute to the
flexibility in the positioning of different lysines for substrate
ubiquitination, such as the E3-mediated positioning of lysines
toward the E2Ub thioester. Lysine selection flexibility may
also be achieved by the release of the ubiquitin-charged
Cdc34Ub from SCF to transfer Ub to different substrate
lysines, as proposed by the “hit-and-run” hypothesis (5). Our
studies now demonstrate that in addition to these higher-order
effects, amino acids immediately proximal to lysines also play
an important role in catalysis, suggesting that the interplay of
both mechanisms ultimately defines the efficiency of the ubiq-
uitination of a lysine. SCFCdc4/Cdc34 displayed a clear prefer-
ence toward Sic1 K53. The importance of the sequence envi-
ronment was first exemplified by our studies mutating residues
around Sic1 lysines, where changes to proximal amino acids
consistently reduced or increased ubiquitination. Importantly,
FIG. 7. Sequence-dependent ubiquitination is intrinsic to Cdc34. (A) Cdc34 mutants were analyzed in autoubiquitination reactions with
Ub(Wt). Autoubiquitinated E2 (E2-Ubn) and unanchored di-Ub (Ub2) are indicated. A truncated version of Cdc34 (200) missing the C-terminal
autoubiquitination sites and yeast Ubc4, which is inefficient in di-Ub synthesis (13), were employed as controls. The truncated Cdc34 (200)
efficiently synthesized unanchored di-Ub (Ub2) and high-molecular-mass Ub chains (Ubn) of 150 to 250 kDa (lane 13). Ubc4, which autoubiq-
uitinates, generated predominantly monoubiquitinated Ubc4 (Ubc4-Ub1) and failed to form unanchored Ub2 (lane 14). (B) The autoubiquitination
of Cdc34 and the YDA mutant with Ub(Wt), Ub(G47Q), Ub(Q49P), Ub(L50S), or Ub(K48R) was monitored as described above (A) except that
Cdc34 was 32P labeled. (C) The autoubiquitination of Cdc34 and the YDA mutant with Ub(Wt), Ub(Q49P), or Ub(L50S) was monitored as
described above (B) for the indicated times. (D) Amino acid changes proximal to K48 of ubiquitin alter the Vmax of Ub chain synthesis by
Cdc34(YDA). The effect of the Ub concentration (0.5 to 20 M) on the rate of Ub chain extension by wild-type Cdc34 (lanes 1 to 7) and the YDA
mutant (lanes 8 to 14) was measured in autoubiquitination reaction mixtures containing the indicated concentrations of 32P-labeled Ub(Wt) (top),
Ub(Q49P) (middle), and Ub(L50S) (bottom). Autoubiquitinated Cdc34 (Cdc34-Ubn) and unanchored di-Ub (Ub2) and tri-Ub (Ub3) are indicated
on the right-hand side. Cdc34-Ub conjugates of wild-type Cdc34 and Cdc34(YDA) with more than four Ub moieties (number of major
autoubiquitination sites) were quantified by PhosphorImager analysis to calculate the apparent Vmax and Km of the Ub chain extension on Cdc34
by nonlinear regression with GraphPad Prism software. Data in parentheses indicate standard errors.
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the growth rate of S. cerevisiae expressing the different single-
lysine Sic1 mutants or the K53 sequence mutants correlated
with their level of ubiquitination in vitro, indicating that se-
quence-dependent ubiquitination is physiologically important
(Fig. 1 and 2). This was due to the altered stability of Sic1 in S.
cerevisiae, as exemplified by Sic1 K53 and Sic1 K32 and their
derivatives. The importance of Sic1 lysine selectivity during
ubiquitination is exemplified by studies demonstrating that the
half-life of Sic1 ubiquitinated on K36 or K84 is 1 min or 5 min,
respectively, indicating that the context of Sic1 lysine ubiquiti-
nation is important for proteolysis (20).
In addition to Sic1 lysines, we observed that alterations
around Ub K48 can affect polyubiquitination by Cdc34. Hence,
catalysis was severely impaired with Ub(G47Q), while Ub
(Q49P) and Ub(L50S) did not affect the utilization of K48 for
polyubiquitination. Previous reports have shown that G47 of
Ub is important for yeast cell growth and Ub conjugation via
K48 (21, 31). Similar to the E3-mediated positioning of sub-
strate lysines, structural aspects of some E2s, such as Ubc13
and Cdc34, position Ub lysines to generate Ub chains of a
specific topology (11, 12, 21, 36). However, E2s such as human
UbcH5 can utilize all Ub lysines but display a preference for
K11, K48, and K63, indicating less structural constraint and
that other mechanisms contribute to Ub lysine specificity (12).
Our work suggests that amino acids proximal to lysines in Ub
may provide a further level of specificity control with cer-
tain E2s.
Importantly, our studies show that ubiquitination is linked to
key residues in the catalytic core of Cdc34, which can differ-
entially regulate initial substrate ubiquitination and Ub chain
extension via K48. It is unclear if the divergence of residues
surrounding the catalytic cysteine in different E2s is function-
ally important. Our results argue that this divergence may have
evolved to contribute to lysine specificity in substrates and Ub.
Previous studies underscored the importance of the analogous
sites in other E2s. Studies of Ubc9 in complex with the
substrate RanGAP1 demonstrated that Ubc9 N85, Y87, and
D127 facilitate catalysis through the optimal alignment and
nucleophilic activation of the attacking lysine within the active
site (38). The human Cdc34(Y87A) and Cdc34(S138A) mu-
tants are impaired in IB ubiquitination (7). The yeast
Ubc13(D81K) mutant is completely inactive (35). Our studies
delineate their specific importance, showing that these residues
are important for lysine selectivity and can specify if Sic1 is
monoubiquitinated or polyubiquitinated. This was strikingly
exemplified by the YDA and NSA mutants, which displayed
polar-opposite activities toward lysines of Sic1 and K48 of Ub.
Hence, the YDA mutant was as active as Cdc34 in the ubiq-
uitination of Sic1 but essentially inactive toward K48 of Ub.
Conversely, the NSA mutant was significantly impaired in Sic1
ubiquitination but active toward K48 of Ub (Fig. 4 and 5 and
Table 3). Therefore, these mutants display dichotomy and are
not inactive per se but rather in their specificity toward partic-
ular acceptor lysines. These studies strongly suggest that dif-
ferent combinations of residues in the catalytic regions of E2s
are not functionally redundant. E2s may have evolved different
active-site structures for the optimal ubiquitination of specific
lysines in a particular range of substrates and possibly in dic-
tating whether a substrate is mono- or polyubiquitinated. The
regulatory nature of the site analogous to Cdc34 S139 is fur-
ther illustrated in E2s such as hHR6A, which is phosphorylated
by CDKs on serine at this position (S120) to regulate activity
(27), although not all E2s with serine in this position are
phosphorylated at this site, e.g., Cdc34 (3, 24). By recruiting a
particular E2 or E2s, E3 may specify the mode of substrate
ubiquitination. In support of this notion, although E3s such as
SCF and human APC/C use single E2s for attaching Ub to
both substrate and Ub lysines, other E3s utilize different E2s
for specific roles during polyubiquitination. Hence, yeast
APC/C utilizes Ubc4 and Ubc1 for ubiquitinating cyclin B (23).
Ubc4 catalyzes cyclin B monoubiquitination, while Ubc1 cata-
lyzes further K48-mediated polyubiquitination.
Our studies with the YDA mutant highlighted the impor-
tance of compatibility between the lysine environment and E2
core residues. While this mutant was impaired in its ability to
utilize Ub K48, changes to the proximal residues (Q49P and
L50S) restored the activity of this mutant in Ub chain assembly
(Fig. 6 and 7B). Although the structure of yeast Cdc34 is not
known, the catalytic domain of E2 enzymes is highly conserved
(22). Structure-function studies of the E2-substrate complex of
human Ubc9 and RanGAP1 showed that the sites analogous to
Cdc34 Y89, S139, and A141 (Ubc9 Y87, D127, and A129)
surround the catalytic cysteine. Ubc9 Y87 and A129 make van
der Waals contacts with L525, S527, and E528 of RanGAP1,
which are proximal to the sumoylated K526, while D127 is
within hydrogen-bonding distance of sumoylated K526 (2, 38).
These interactions are important for sumoylation through op-
timal alignment and pK suppression for the nucleophilic acti-
vation of the attacking lysine (2, 38). Our studies suggest that
similar contacts between the Cdc34 core sites and the ubiquiti-
nation site sequence are important for catalysis. Our kinetic
studies suggest that compatibility is important for lysine acti-
vation rather than substrate binding. Alternatively, it is possi-
ble that some of the Cdc34 residues examined in this study may
be important for facilitating Cdc34 activity via self-association,
which is important for its catalytic activity (36). However, these
studies demonstrated that the active-site cysteine and serines
73 and 97, which are distinct from the sites evaluated in this
study, are important for oligomerization. Future structural
studies of the Cdc34-substrate complex will provide further
insights into these issues.
In agreement with our findings, recent studies with UbcH10
and its cognate E3, APC/C, demonstrated that a sequence
motif, termed the TEK box, surrounding lysines in the sub-
strate and Ub K11 is important for ubiquitination (11). In
addition, proteins with Ub binding domains (UBDs) can be
ubiquitinated directly by E2s without E3s (10). It is postulated
that the substrate UBD binds to the Ub conjugated to the E2
and that Ub is then transferred to the substrate lysine. Seven
different E2s displayed differential specificity toward different
UBD proteins, raising the issue of how a particular UBD
substrate is selected for ubiquitination by a particular E2, since
there is no E3 to direct specificity. Our studies suggest that the
compatibility of the E2 catalytic core with residues surrounding
potential target lysines is important for controlling specificity
between particular E2s and UBD proteins.
Altogether, these findings demonstrate that in addition to
the importance of higher-order structural features of SCFCdc4
and Cdc34 or models such as the “hit-and-run” hypothesis,
which position different lysines for the attack of the Cdc34Ub
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thioester bond, compatibility between key residues within the
Cdc34 catalytic region and those proximal to acceptor lysines
provides a further level of specificity control. E2s may have
evolved divergent structures in their catalytic regions to mod-
ulate lysine specificity. It will be interesting to comprehensively
define all the important determinants in the catalytic region of
E2s and residues proximal to acceptor lysines to define if this
is a general feature of E2-mediated ubiquitination.
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